alpha and beta-D-Glucopiranose Pentakis(2,3,4-trihydroxybenzoate)

ID: ALA4474868

Chembl Id: CHEMBL4474868

PubChem CID: 155537546

Max Phase: Preclinical

Molecular Formula: C41H32O26

Molecular Weight: 940.68

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(OC[C@H]1OC(OC(=O)c2ccc(O)c(O)c2O)[C@H](OC(=O)c2ccc(O)c(O)c2O)[C@@H](OC(=O)c2ccc(O)c(O)c2O)[C@@H]1OC(=O)c1ccc(O)c(O)c1O)c1ccc(O)c(O)c1O

Standard InChI:  InChI=1S/C41H32O26/c42-17-6-1-12(23(47)28(17)52)36(57)62-11-22-33(64-37(58)13-2-7-18(43)29(53)24(13)48)34(65-38(59)14-3-8-19(44)30(54)25(14)49)35(66-39(60)15-4-9-20(45)31(55)26(15)50)41(63-22)67-40(61)16-5-10-21(46)32(56)27(16)51/h1-10,22,33-35,41-56H,11H2/t22-,33-,34+,35-,41?/m1/s1

Standard InChI Key:  OASOWVSDFOIYRU-UTWXLTRVSA-N

Alternative Forms

  1. Parent:

    ALA4474868

    ---

Associated Targets(Human)

ANTXR2 Tchem Anthrax toxin receptor 2 (35 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 940.68Molecular Weight (Monoisotopic): 940.1182AlogP: 1.69#Rotatable Bonds: 11
Polar Surface Area: 444.18Molecular Species: NEUTRALHBA: 26HBD: 15
#RO5 Violations: 3HBA (Lipinski): 26HBD (Lipinski): 15#RO5 Violations (Lipinski): 3
CX Acidic pKa: 7.94CX Basic pKa: CX LogP: 8.24CX LogD: 8.19
Aromatic Rings: 5Heavy Atoms: 67QED Weighted: 0.05Np Likeness Score: 0.59

References

1. G-Doyagüez E, Carrero P, Madrona A, Rodriguez-Salamanca P, Martínez-Gualda B, Camarasa MJ, Jimeno ML, Bennallack PR, Finnell JG, Tsang TM, Christensen KA, San-Félix A, Rogers MS..  (2019)  Galloyl Carbohydrates with Antiangiogenic Activity Mediated by Capillary Morphogenesis Gene 2 (CMG2) Protein Binding.,  62  (8): [PMID:30964669] [10.1021/acs.jmedchem.8b01988]

Source